Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of New Direct Acting Agents For Hepatitis C

NCT02485262 is registered in ClinicalTrials.gov with Arrowhead Regional Medical Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02485262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of New Direct Acting Agents For Hepatitis C
Lead sponsor
Arrowhead Regional Medical Center
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2013
Completion date
November 30, 2016
Enrollment
340 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.